                         SEQUENCE LISTING

<110>  UNIVERSITY OF WASHINGTON
       CHENG, Yilong
       PUN, Suzie H
 
<120>  MEMBRANE-LYTIC BLOCK COPOLYMERS

<130>  17-736-PCT

<140>  PCT/US2017/045566
<141>  2017-08-04

<150>  US 62/371,163
<151>  2016-08-04

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HGP peptide

<400>  1

Leu Leu Gly Arg Arg Gly Trp Glu Val Leu Lys Tyr Trp Trp Asn Leu 
1               5                   10                  15      


Leu Gln Tyr Trp Ser Gln Glu Leu 
            20                  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  sHGP peptide

<400>  2

Arg Gly Trp Glu Val Leu Lys Tyr Trp Trp Asn Leu Leu Gln Tyr 
1               5                   10                  15  


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TAT peptide

<400>  3

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln 
1               5                   10          


<210>  4
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CaLL

<400>  4

Lys Trp Lys Leu Phe Lys Lys Ile Phe Lys Arg Ile Val Gln Arg Ile 
1               5                   10                  15      


Lys Asp Phe Leu Arg 
            20      


<210>  5
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  hadrurin

<400>  5

Gly Ile Leu Asp Thr Ile Lys Ser Ile Ala Ser Lys Val Trp Asn Ser 
1               5                   10                  15      


Lys Thr Val Gln Asp Leu Lys Arg Lys Gly Ile Asn Trp Val Ala Asn 
            20                  25                  30          


Lys Leu Gly Val Ser Pro Gln Ala Ala 
        35                  40      


<210>  6
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cupiennin 1a

<400>  6

Gly Phe Gly Ala Leu Phe Lys Phe Leu Ala Lys Lys Val Ala Lys Thr 
1               5                   10                  15      


Val Ala Lys Gln Ala Ala Lys Gln Gly Ala Lys Tyr Val Val Asn Lys 
            20                  25                  30          


Gln Met Glu 
        35  


<210>  7
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  crabolin


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-terminus fluorenylmethyloxycarbonyl group

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  C-terminus amide group

<400>  7

Phe Leu Ala Leu Ile Leu Arg Lys Ile Val Thr Ala Leu 
1               5                   10              


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  IsCT


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  C-terminus amine group

<400>  8

Ile Leu Gly Lys Ile Trp Glu Gly Ile Lys Ser Leu Phe 
1               5                   10              


<210>  9
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HsAP


<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  C-terminus amine group

<400>  9

Ser Gly Thr Ser Glu Lys Glu Arg Glu Ser Gly Arg Leu Leu Gly Val 
1               5                   10                  15      


Val Lys Arg Leu Ile Val Cys Phe Arg Ser Pro Phe Pro 
            20                  25                  


<210>  10
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Pandinin2

<400>  10

Phe Trp Gly Ala Leu Ala Lys Gly Ala Leu Lys Leu Ile Pro Ser Leu 
1               5                   10                  15      


Phe Ser Ser Phe Ser Lys Lys Asp 
            20                  


<210>  11
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ponericin

<400>  11

Trp Leu Gly Ser Ala Leu Lys Ile Gly Ala Lys Leu Leu Pro Ser Val 
1               5                   10                  15      


Val Gly Leu Phe Lys Lys Lys Lys Gln 
            20                  25  


<210>  12
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  UyCT5


<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  C-terminus amine group

<400>  12

Ile Trp Ser Ala Ile Trp Ser Gly Ile Lys Gly Leu Leu 
1               5                   10              


<210>  13
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cysteine-melittin


<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  C-terminus amide group

<400>  13

Gly Ile Gly Ala Val Leu Lys Val Leu Thr Thr Gly Leu Pro Ala Leu 
1               5                   10                  15      


Ile Ser Trp Ile Lys Arg Lys Arg Gln Gln Cys 
            20                  25          


